Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04055870 · ClinicalTrials.gov registry record
Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 24
- Enrollment target
NCT04055870 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 24 participants.
The verdict
NCT04055870 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy, safety, and adequacy of EUS-guided liver biopsy in patients undergoing EUS-guided liver biopsy at Methodist Dallas Medical Center (MDMC).
Interventions
- PROCEDURE EUS-guided liver biopsy at MDMC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-08-21 |
| Est. Completion | 2020-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04055870
The ClinicalTrials.gov registry entry for NCT04055870 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EUS-guided liver biopsy at MDMC is the first listed.
NCT04055870 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04055870 about?
NCT04055870 is a clinical study titled "Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy". The purpose of this study is to evaluate the efficacy, safety, and adequacy of EUS-guided liver biopsy in patients undergoing EUS-guided liver biopsy at Methodist Dallas Medical Center (MDMC).
What is the current status of trial NCT04055870?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2017-08-21. Estimated completion is 2020-10-30.
What interventions are being tested in trial NCT04055870?
The interventions under investigation include: EUS-guided liver biopsy at MDMC (PROCEDURE).
Who is sponsoring clinical trial NCT04055870?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.